Literature DB >> 15790845

Immunity, inflammation, and allergy in the gut.

Thomas T Macdonald1, Giovanni Monteleone.   

Abstract

The gut immune system has the challenge of responding to pathogens while remaining relatively unresponsive to food antigens and the commensal microflora. In the developed world, this ability appears to be breaking down, with chronic inflammatory diseases of the gut commonplace in the apparent absence of overt infections. In both mouse and man, mutations in genes that control innate immune recognition, adaptive immunity, and epithelial permeability are all associated with gut inflammation. This suggests that perturbing homeostasis between gut antigens and host immunity represents a critical determinant in the development of gut inflammation and allergy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15790845     DOI: 10.1126/science.1106442

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  282 in total

1.  Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.

Authors:  Chang Liu; Zhuo-Yang Zhang; Ke Dong; Xiao-Kui Guo
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Distinct compartmentalization of NF-κB activity in crypt and crypt-denuded lamina propria precedes and accompanies hyperplasia and/or colitis following bacterial infection.

Authors:  Parthasarathy Chandrakesan; Ishfaq Ahmed; Anisha Chinthalapally; Pomila Singh; Shanjana Awasthi; Shrikant Anant; Shahid Umar
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

3.  Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls.

Authors:  Mustafa Erhan Altunöz; Ebubekir Senateş; Atakan Yeşil; Turan Calhan; Ayşe Oya Kurdaş Ovünç
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

4.  Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes.

Authors:  Lena Tasse; Juliette Bercovici; Sandra Pizzut-Serin; Patrick Robe; Julien Tap; Christophe Klopp; Brandi L Cantarel; Pedro M Coutinho; Bernard Henrissat; Marion Leclerc; Joël Doré; Pierre Monsan; Magali Remaud-Simeon; Gabrielle Potocki-Veronese
Journal:  Genome Res       Date:  2010-09-14       Impact factor: 9.043

Review 5.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

6.  Inside the microbial and immune labyrinth: totally gutted.

Authors:  Thomas T Macdonald
Journal:  Nat Med       Date:  2010-11       Impact factor: 53.440

7.  Severe spruelike enteropathy associated with olmesartan.

Authors:  Alberto Rubio-Tapia; Margot L Herman; Jonas F Ludvigsson; Darlene G Kelly; Thomas F Mangan; Tsung-Teh Wu; Joseph A Murray
Journal:  Mayo Clin Proc       Date:  2012-06-22       Impact factor: 7.616

8.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

9.  Effects of trefoil peptide 3 on expression of TNF-alpha, TLR4, and NF-kappaB in trinitrobenzene sulphonic acid induced colitis mice.

Authors:  Xu Teng; Ling-Fen Xu; Ping Zhou; Hong-Wei Sun; Mei Sun
Journal:  Inflammation       Date:  2009-04       Impact factor: 4.092

Review 10.  Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease.

Authors:  Noah P Zimmerman; Rebecca A Vongsa; Michael K Wendt; Michael B Dwinell
Journal:  Inflamm Bowel Dis       Date:  2008-07       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.